247 related articles for article (PubMed ID: 8053971)
1. Alcohol tolerance in patients with non-insulin-dependent (type 2) diabetes treated with sulphonylurea derivatives.
Lao B; Czyzyk A; Szutowski M; Szczepanik Z
Arzneimittelforschung; 1994 Jun; 44(6):727-34. PubMed ID: 8053971
[TBL] [Abstract][Full Text] [Related]
2. [Alcohol tolerance in patients with non-insulin-dependent diabetes (type 2) treated orally with drugs--derivatives of sulphonylurea].
Lao B; Czyzyk A; Szutowski M; Szczepanik Z
Pol Arch Med Wewn; 1993 Jun; 89(6):463-79. PubMed ID: 8415209
[TBL] [Abstract][Full Text] [Related]
3. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
Sönksen PH; Lowy C; Perkins JR; Lim HS
Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of alcohol-induced hypoglycaemia by H2-receptor antagonists.
Czyzyk A; Lao B; Szutowski M; Szczepanik Z; Muszyński J
Arzneimittelforschung; 1997 Jun; 47(6):746-9. PubMed ID: 9239453
[TBL] [Abstract][Full Text] [Related]
5. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
6. The formation of acetate from ethanol with and without prior chlorpropamide intake in diabetic and non-diabetic subjects.
Akanji AO; Hockaday TD
Afr J Med Med Sci; 1991 Jun; 20(2):69-73. PubMed ID: 1908625
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
Saxena T; Maheshwari S; Goyal RK
J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
[TBL] [Abstract][Full Text] [Related]
8. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
10. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
Khandekar S; Sethi BK; Dash RJ
J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
[TBL] [Abstract][Full Text] [Related]
11. Roles of chlorpropamide, alcohol and acetaldehyde in determining the chlorpropamide-alcohol flush.
Groop L; Eriksson CJ; Huupponen R; Ylikahri R; Pelkonen R
Diabetologia; 1984 Jan; 26(1):34-8. PubMed ID: 6706043
[TBL] [Abstract][Full Text] [Related]
12. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
[TBL] [Abstract][Full Text] [Related]
13. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.
Iwamoto Y; Kosaka K; Kuzuya T; Akanuma Y; Shigeta Y; Kaneko T
Diabet Med; 1996 Apr; 13(4):365-70. PubMed ID: 9162613
[TBL] [Abstract][Full Text] [Related]
14. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
Sieradzki J; Soszyński P
Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
[TBL] [Abstract][Full Text] [Related]
16. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
Gudat U; Bungert S; Kemmer F; Heinemann L
Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
[TBL] [Abstract][Full Text] [Related]
17. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
18. [Circadian profiles of lactic and pyruvic acid in diabetic patients treated with biguanides and sulfonylureas].
Cheli V; Buzzo P; Melga P; Accoto S; Prando R
Clin Ter; 1986 Aug; 118(4):269-75. PubMed ID: 3757467
[No Abstract] [Full Text] [Related]
19. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
